Improving suicide prevention strategies for teens
Advancing Suicide Intervention Strategies for Teens During High Risk Periods
NA · Seattle Children's Hospital · NCT05078970
This study is testing two new ways to help teens aged 11-17 who are at risk of suicide to see if they work better than regular care.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 306 (estimated) |
| Ages | 11 Years to 17 Years |
| Sex | All |
| Sponsor | Seattle Children's Hospital (other) |
| Locations | 2 sites (Columbus, Ohio and 1 other locations) |
| Trial ID | NCT05078970 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of two interventions, Safety Planning Intervention with follow-up (SPI+) and Collaborative Assessment and Management of Suicidality (CAMS), compared to usual care for adolescents at risk of suicide. Participants, aged 11-17, who have experienced suicidal ideation or behavior, will receive assessments at multiple time points to track their progress and the impact of the interventions. The study aims to identify the mechanisms behind the therapeutic effects and determine which factors influence treatment outcomes. Both adolescents and their parents will be involved in the research process.
Who should consider this trial
Good fit: Ideal candidates are adolescents aged 11-17 who have endorsed suicidal thoughts or behaviors and have been admitted to acute care due to suicidality.
Not a fit: Patients with psychosis, intellectual disabilities, autism spectrum disorder, or unstable eating disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more effective suicide prevention strategies for adolescents, potentially reducing suicide attempts and ideation.
How similar studies have performed: Other studies have shown promise in similar intervention approaches, suggesting potential for success in this area.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Provision of signed and dated informed consent form 2. Youth, aged 11-17 3. Endorse suicidal ideation and/or behavior 4. Admitted to acute care (emergency, inpatient medical or inpatient psychiatric) due to suicidality Exclusion Criteria: 1. Presence of psychosis, intellectual disability, autism spectrum disorder, eating disorder with unstable vitals 2. Limited English proficiency that would interfere with the ability to complete study assessments
Where this trial is running
Columbus, Ohio and 1 other locations
- Nationwide Children's — Columbus, Ohio, United States (RECRUITING)
- Seattle Children's — Seattle, Washington, United States (RECRUITING)
Study contacts
- Principal investigator: Molly Adrian — Seattle Childrens
- Study coordinator: Molly Adrian
- Email: molly.adrian@seattlechildrens.org
- Phone: 206-987-7183
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Suicide Attempts, Suicidal Ideation, Suicide and Self-harm, Suicide Threat